Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Transparency Life Sciences

Transparency Life Sciences?uq=UG6efJS6
2011 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$5M LATEST DEAL AMOUNT
2 INVESTORS
Description

Provider of a digital drug development service designed to transform clinical trial design and execution. The company's platform combines crowdsourcing and mobile health technology to advance drug candidates through clinical trials with patient convenience, data relevance, efficiency and affordability, enabling clinical trial sponsors to achieve better results at lower cost.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • 34 West 34th Street, 804
  • New York, NY 10001
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Transparency Life Sciences’s full profile, request a free trial.

Transparency Life Sciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 15-Feb-2018 $5M 000 0000 Completed Generating Revenue
2. Grant 08-Sep-2014 00.00 Completed Startup
1. Seed Round 17-Jul-2011 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Transparency Life Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Transparency Life Sciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
New Ventures Fund Venture Capital Minority 000 0000 000000 0
Small Business Innovation Research Government 000 0000 000000 0

Transparency Life Sciences Executive Team (3)

Name Title Board
Seat
Contact
Info
Tomasz Sablinski Ph.D Chief Executive Officer, Board Member and Co-Founder
Marc Foster Chief Operating Officer, Board Member and Co-Founder
Scott Becker Advisor

Transparency Life Sciences Board Members (6)

Name Representing Role Since Contact
Info
Harry Glorikian New Ventures Fund Board Member 000 0000
John Watson Self Board Member 000 0000
Lawrence Steinman MD Self Scientific Advisory Board Chairman 000 0000
Marc Foster Transparency Life Sciences Chief Operating Officer, Board Member and Co-Founder 000 0000
Richard Warburg Ph.D New Ventures Fund Board Member & Advisor 000 0000
You’re viewing 5 of 6 board members. Get the full list »